Advertisement

Topics

Alvogen Inc. Company Profile

09:50 EDT 18th June 2018 | BioPortfolio

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group’s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen has commercial operations in over 30 countries with 1,900 employees. Alvogen welcomes inquiries regarding partnering opportunities. Please contact Alexander Mironov, Vice President, Business Development, at +1.973.487.3951 for more information.


News Articles [7 Associated News Articles listed on BioPortfolio]

Alvogen Obtains European Approvals for Generic Lenalidomide

Alvogen today announced that it has successfully concluded multiple registration procedures for Lenalidomide capsules. Alvogen received regulatory clearance for its product in sev...

Alvogen receives European approval for generic lenalidomide

US generics company Alvogen announced on 24 April 2018 that it had successfully concluded multiple registration procedures for its lenalidomide generic capsules.

Indivior rocked by loss of patent case

Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of Alvogen over claims of patent infringement. The case relates to Indivior’s lead product,...

Indivior to fight U.S. court ruling in favor of competitor drug

LONDON (Reuters) - Britain's Indivior, the maker of opioid addiction treatment Suboxine Film, said it would fight a U.S. court ruling in favor of would-be generic competitor Alvogen that could pave th...

Indivior files patent lawsuits against Teva, Dr Reddy's and others

Indivior has filed patent lawsuits against Dr. Reddy's, Actavis, Par, Alvogen and Teva for infringement of United States Patent No. 9,931,305 (the '305 patent) relating to their respective proposed ge...

Alvogen Korea Co Ltd 002250 Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryAlvogen Korea Co Ltd Alvogen, formerly KunWha Pharmaceutical Co Ltd, a subsidiary of Alvogen Inc is a manufacturer of prescription pharmaceuticals for use in various therapeutic areas. The comp...

Alvogen Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27112017] Prices from USD $250

SummaryAlvogen Inc Alvogen develops, manufactures and markets biosimilar products, generic pharmaceuticals and OTC products. The company's product portfolio comprises generic medications in various th...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%) to Estrace® Cream (0.01%) in Postmenopausal Females With Atrophic Vaginitis

The purpose of this study is to determine the therapeutic equivalence of Alvogen's estradiol vaginal cream to Estrace® cream and superiority of both products to placebo. The protocol desc...

Companies [4 Associated Companies listed on BioPortfolio]

Alvogen Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen Pharma US, Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen, Inc. Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

More Information about "Alvogen Inc." on BioPortfolio

We have published hundreds of Alvogen Inc. news stories on BioPortfolio along with dozens of Alvogen Inc. Clinical Trials and PubMed Articles about Alvogen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alvogen Inc. Companies in our database. You can also find out about relevant Alvogen Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record